Clinical Trials Using Technetium Tc-99m Albumin Aggregated

Clinical trials are research studies that involve people. The clinical trials on this list are studying Technetium Tc-99m Albumin Aggregated. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • FLARE RT for Patients with Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET / CT and SPECT / CT Imaging

    This phase II trial studies how well positron emission tomography (PET) / computed tomography (CT) and single positron emission computed tomography (SPECT) / CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET / CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT / CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity.
    Location: 2 locations

  • Tc99m-MAA Imaging for Radiation Therapy Planning in Patients with Lung Cancer or Lung Metastases

    This phase I trial studies how well Tc99m-MAA imaging works for radiation therapy planning in patients with lung cancer or cancer that has spread to the lungs (lung metastases). Arterial administration of radiation to lung tumors may represent an alternative method of radiation therapy, with dose directly administered to the tumor. The potential radiation dose to the tumor and adjacent structures is not known. Tc99m-MAA is a type of radiotracer that is used to assess blood flow and has a similar size to the particles that are utilized for arterial delivery of radiation therapy. Giving Tc99m-MAA, followed by scans called single photon emission computed tomography (SPECT) and planar imaging, may allow doctors to estimate radiation dose to tumors and adjacent structures in the setting of intra-arterial radiation therapy.
    Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts